Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study

Grachev ID, Meyer PM, Becker GA, et al. Eur J Nucl Med Mol Imaging. 2021;48(4):1103-1115. doi:10.1007/s00259-020-05030-3